Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Visioneering Technologies.
RELATED STOCKHEAD STORIES
News
Market Highlights: Tech rally on Nasdaq, commodities bounce back, and 5 ASX small caps to watch today
News
Market Highlights: ASX set to rise again, Birkenstock’s disappointing IPO, and 5 ASX small caps to watch today
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: War – Gold – Oil – The ASX – Monday
Tech
ASX Tech September Winners: Sluggish September cures Wall Street’s IPO fever
Health & Biotech
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?
News
Market Highlights: Bank chiefs spook Wall Street, and 5 ASX small caps to watch on Wednesday
Health & Biotech
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Experts
Twenty-One of the Best: Tim Boreham’s Hot Stocks for 2022
Health & Biotech
Dr Boreham’s Crucible: Visoneering’s taking the longview on short-sightedness – and it’s starting to pay off
Health & Biotech
China is about to grant patents like never before, and these ASX stocks have already got some
Health & Biotech
ASX Health Stocks: Visioneering jumps 13pc on contact lenses launch, Sigma drops bid for API
News
10 at 10: These ASX stocks are illuminated the most brightly this morning
Health & Biotech
ASX Health Stocks: Chimeric gets FDA clearance, Cochlear posts record sales
News
Market Highlights and 5 ASX Small Caps to watch on Friday
Tech
